Phase 2 Study of V565, Anti-TNF Antibody, in Crohn’s Patients Begins
News
VHsquared announced the first patients have entered HARBOR, an international Phase 2 clinical trial examining the efficacy of V565 ( an anti-TNFα oral antibody) in treating Crohn’s disease. The study is ... Read more